MarketPulse

lawsuit settlement

2 articles
The Motley FoolThe Motley Fool··Dave Kovaleski

Major Asset Manager Exits $18M Hims & Hers Position Ahead of Novo Nordisk Reconciliation

BLKBRD Asset Management fully exits $18M Hims & Hers position in Q4 2025, just before company reconciles with Novo Nordisk.
NVDAGOOGGOOGLNVOHIMSpartnershipweight loss drugs
The Motley FoolThe Motley Fool··Geoffrey Seiler

Hims & Hers Surges 40% on Novo Nordisk Deal, But Valuation Concerns Linger

Hims & Hers surges 40% after Novo Nordisk partnership resolves litigation, enabling authorized distribution of Wegovy and Ozempic. Stock trades under 20x forward P/E.
NVOHIMSGLP-1 drugstelemedicine